For research use only. Not for therapeutic Use.
25I-<wbr></wbr>NBMD is a derivative of the phenethylamine hallucinogen 2C-<wbr></wbr>I, characterized by the addition of a methylenedioxy-<wbr></wbr>benzyl group to the amine. This addition increases the affinity (K<sub>i</sub> = 0.049–0.21 nM) and activity (EC<sub>50</sub> = 8.2 nM) at the serotonin receptor 5-<wbr></wbr>HT<sub>2A</sub>. This product is intended for research and forensic applications.
| Catalog Number | R061677 |
| CAS Number | 1539266-14-2 |
| Synonyms | Cimbi-29 |
| Molecular Formula | C18H20INO4 • HCl |
| Purity | ≥95% |
| Storage | -20°C |
| InChI | InChI=1S/C18H20INO4.ClH/c1-21-16-9-14(19)17(22-2)8-12(16)6-7-20-10-13-4-3-5-15-18(13)24-11-23-15;/h3-5,8-9,20H,6-7,10-11H2,1-2H3;1H |
| InChIKey | QKMOLNYYXDCGFL-UHFFFAOYSA-N |
| SMILES | IC1=C(OC)C=C(CCNCC2=C(OCO3)C3=CC=C2)C(OC)=C1.Cl |
| Reference | 1.Ettrup, A.,Hansen, M.,Santini, M.A., et al. Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT2A agonist PET tracers. Eur.J.Nucl.Med.Mol.Imaging 38, 681-693 (2011). |
